The goal of the Contrails project is to help preserve and disseminate the technical record of 20th century aerospace research, highlighting in particular the research endeavors of the Illinois Tech community.

Antiarrhythmic Activity of Antazoline and its Application to the Control of Hypothermic Ventricular Fibrillation

Report Number: AMRL TR 65-201
Author: Angelakos, E. T.
Corporate Author: Boston University School of Medicine
Laboratory: Aerospace Medical Research Laboratories
Date of Publication: 1965-12
Pages: 36
Contract: AF 33(657)-10755
Project: 7164
Task: 716409
AD Number: AD0629548

The chemistry and general pharmacology of antazoline and experimental studies employing it are reviewed to determine the antiarrhythmic activity and the protective effect of antazoline against hypothermic ventricular fibrillation. In hypothermic ventricular fibrillation and in clinically observed heart disorders, the antiarrhythmic activity of antazoline was often superior to other pharmacological agents, including quinidine. The incidence of side effects, notably nausea or vomiting, was found to be related to the dosage. Since the basis of the antiarrhythmic activity of antazoline is essentially unknown, further studies in this direction are warranted to provide for systematic development of more effective compounds.

RAF Centre of Aviation Medicine
Download this report

(PDF, 1.08 MB, 36 pages)

Other options for obtaining this report

Via the Defense Technical Information Center (DTIC):
A record for this report, and possibly a full-image download of the report, exists at DTIC

Via National Technical Information Service:
This report may have been digitized and made freely available for public download, or made publicly available for purchase by the National Technical Information Service through their online database, the National Technical Reports Library

Indications of Public Availability
No digital image of an index entry indicating public availability is currently available
There has been no verification of an indication of public availability from an inside cover statement